Browse EX-10 agreements

DEMAND PROMISSORY NOTE

** **

$250,000	August 26, 2026

** **

FOR VALUE RECEIVED, VEEA INC., a Delaware corporation (the “Company”), hereby promises to pay to the order of NLabs Inc., a Delaware corporation or such holder’s assigns (“Holder”), the principal sum of TWO HUNDRED AND FIFTY THOUSAND DOLLARS AND NO CENTS ($250,000) (the “Principal Amount”) together with interest thereon from the date hereof to maturity at a simple interest at the rate of ten percent (10%) per annum, calculated on the basis of a 365-day year and actual days elapsed since the issuance of this Demand Promissory Note (this “Note”).

---

The Principal Amount is due on demand, and in the absence of any demand is due on December 31, 2026. All installments, prepayments, and other payments of principal and interest are payable to Holder in cash in immediately available funds to the account designed by Holder.

…

AMENDMENT NO. 1 TO SPONSOR AGREEMENT

THIS AMENDMENT (this “Amendment”) to the Sponsor Agreement, dated as of December 10, 2025 by and between 21Shares US LLC, a Delaware limited liability company (the “Sponsor”) and 21Shares XRP ETF (the “Trust” and such agreement, the “Sponsor Agreement”), is made as of August 26, 2026 (the “Effective Date”) by and between the Sponsor and the Trust.

WHEREAS, reference is made to the Sponsor Agreement; and

WHEREAS, the parties hereto desire to amend certain provisions of the Sponsor Agreement as more particularly described below.

NOW, THEREFORE, in consideration of the foregoing, the Sponsor Agreement is hereby amended as follows:

	1.	Paragraph 7 is amended to the below:

…

THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THE EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

** **

Exhibit 10.1

ONE CONTRACT FRAMEWORK TERMS

These One Contract Framework Terms apply to the provision of Services by Licensor to Licensee and comprise the following:

●	Section 1 – General Terms

●	Section 2 – Definitions

●	Section 3 – Multi-Use Terms

●	Section 4 – Fund and Product Licence Terms

●	Section 5 – End of Day Distribution Terms

…

***SECOND AMENDMENT TO OFFICE LEASE ***

This SECOND AMENDMENT TO OFFICE LEASE (this “Second Amendment”) is made and entered into as of August 5, 2026 (“Effective Date”), by and between KR JUNCTION, LLC, a Delaware limited liability company (“Landlord”), and AVENZO THERAPEUTICS, INC., a Delaware corporation (“Tenant”).

R E C I T A L S :

A. Landlord (as successor-in-interest to BRE CA OFFICE OWNER LLC, a Delaware limited liability company) and Tenant entered into that certain Office Lease dated 11/7/2022 (the “Original Lease”), as amended by that certain First Amendment to Office Lease dated December 6, 2024 (the “First Amendment”, and together with the Original Lease, the “Lease”), whereby Landlord leases to Tenant and Tenant leases from Landlord those certain premises consisting of 23,461 rentable square feet (collectively, the “Existing Premises”) comprised of: (i) that certain space consisting of 3,836 rentable square feet of space commonly known as Suite 100 (“Suite 100”) and located on the first (1st) floor of that ce

…

THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

** **

Exhibit 10.1

** **

ONE CONTRACT FRAMEWORK TERMS

These One Contract Framework Terms apply to the provision of Services by Licensor to Licensee and comprise the following:

	●	Section 1 – General Terms

	●	Section 2 – Definitions

	●	Section 3 – Multi-Use Terms

	●	Section 4 – Fund and Product Licence Terms

	●	Section 5 – End of Day Distribution Terms

…

AMENDMENT NO. 1 TO SPONSOR AGREEMENT

THIS AMENDMENT (this “Amendment”) to the Sponsor Agreement, dated as of February 23, 2026 by and between 21Shares US LLC, a Delaware limited liability company (the “Sponsor”) and 21Shares Sui Staking ETF (the “Trust” and such agreement, the “Sponsor Agreement”), is made as of August 26, 2026 (the “Effective Date”) by and between the Sponsor and the Trust.

WHEREAS, reference is made to the Sponsor Agreement; and

WHEREAS, the parties hereto desire to amend certain provisions of the Sponsor Agreement as more particularly described below.

NOW, THEREFORE, in consideration of the foregoing, the Sponsor Agreement is hereby amended as follows:

	1.	Paragraph 7 is amended to the below:

…

THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

** **

Exhibit 10.1

ONE CONTRACT FRAMEWORK TERMS

These One Contract Framework Terms apply to the provision of Services by Licensor to Licensee and comprise the following:

●	Section 1 – General Terms

●	Section 2 – Definitions

●	Section 3 – Multi-Use Terms

●	Section 4 – Fund and Product Licence Terms

●	Section 5 – End of Day Distribution Terms

…

AMENDMENT NO. 1 TO SPONSOR AGREEMENT

THIS AMENDMENT (this “Amendment”) to the Sponsor Agreement, dated as of January 9, 2026 by and between 21Shares US LLC, a Delaware limited liability company (the “Sponsor”) and 21Shares Dogecoin ETF (the “Trust” and such agreement, the “Sponsor Agreement”), is made as of August 26, 2026 (the “Effective Date”) by and between the Sponsor and the Trust.

WHEREAS, reference is made to the Sponsor Agreement; and

WHEREAS, the parties hereto desire to amend certain provisions of the Sponsor Agreement as more particularly described below.

NOW, THEREFORE, in consideration of the foregoing, the Sponsor Agreement is hereby amended as follows:

	1.	Paragraph 7 is amended to the below:

…

Made this 26th August 2026

** **

SOFTWARE DEVELOPMENT AGREEMENT

** **

** **

**Between **

** **

**TREASURE GLOBAL INC **

(Registration No. 7908921)

** **

(“the Company”)

** **

** **

**AND **

** **

**The person with particular in Section 3 of the First Schedule **

** **

(“Developer”)

** **

**THIS AGREEMENT **is made on this day and year stated in Section 1 of the First Schedule (“the Date of Agreement”).

BETWEEN

The party whose name and particulars are stipulated in Section 2 of the First Schedule (“the Company”) of the one part.

AND

The party whose name and particulars are stipulated in Section 3 of the First Schedule (“the Developer”) of the other part.

The Company and the Developer are hereinafter individually referred to as “the Party” and collectively referred to as “the Parties”.

RECITALS:

…

THE SYMBOL “[***]” DENOTES PLACES WHERE CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH NOT MATERIAL AND IS THE TYPE OF INFORMATION THAT THE REGISTRANT TREATS AS PRIVATE OR CONFIDENTIAL.

** **

Exhibit 10.1

ONE CONTRACT FRAMEWORK TERMS

These One Contract Framework Terms apply to the provision of Services by Licensor to Licensee and comprise the following:

●	Section 1 – General Terms

●	Section 2 – Definitions

●	Section 3 – Multi-Use Terms

●	Section 4 – Fund and Product Licence Terms

●	Section 5 – End of Day Distribution Terms

…

** **

AMENDMENT NO. 1 TO SPONSOR AGREEMENT

THIS AMENDMENT (this “Amendment”) to the Sponsor Agreement, dated as of March 4, 2026 by and between 21Shares US LLC, a Delaware limited liability company (the “Sponsor”) and 21Shares Polkadot Staking ETF (the “Trust” and such agreement, the “Sponsor Agreement”), is made as of August 26, 2026 (the “Effective Date”) by and between the Sponsor and the Trust.

WHEREAS, reference is made to the Sponsor Agreement; and

WHEREAS, the parties hereto desire to amend certain provisions of the Sponsor Agreement as more particularly described below.

NOW, THEREFORE, in consideration of the foregoing, the Sponsor Agreement is hereby amended as follows:

	1.	Paragraph 7 is amended to the below:

…

​

​

PHIBRO ANIMAL HEALTH CORPORATION

EMPLOYMENT** **AGREEMENT

EMPLOYMENT AGREEMENT (this “Agreement”) dated as of July 1, 2026, betweenPhibro** Animal Health **Corporation,aDelawarecorporation(the“Company”),and **Daniel M. Bendheim **(the “Employee”).

W** I T N E S S E T **H

WHEREAS,theCompanydesirestoemploytheEmployeeastheChiefExecutive Officer and President.

**NOW, THEREFORE, **in consideration of the foregoing, of the mutual promises containedhereinandofothergoodandvaluableconsideration,thereceiptandsufficiencyof which are hereby acknowledged, the parties hereto hereby agree as follows:

	1.	POSITION** AND **DUTIES.

…